Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

Credit: Dr Salahuddin Kazi, MD, comments on the challenges of diagnosing seronegative rheumatic diseases and discusses a ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

High blood pressure causes everything from heart attacks and strokes to blindness, kidney failure and erectile dysfunction ...

Assertio (NASDAQ:ASRT – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. Separately, HC ...

Flaxseed packs omega-3s, fiber and lignans into a tiny package. Discover 7 creative ways to enjoy this nutritional powerhouse and the impressive health benefits ...

Learn how to avoid common exercise errors that sabotage your results, waste your time and potentially cause injury—especially ...

This partnership underscores the rising importance of lithium in various sectors, from energy storage to pharmaceuticals.

Equities researchers at Sidoti Csr reduced their Q3 2025 earnings per share (EPS) estimates for shares of Assertio in a note issued to investors on Thursday, March 13th. Sidoti Csr analyst J. Sidoti ...

Interleukin 1-β (IL-1β) is a key mediator of acute gouty flares, and anti-IL-1β therapy has been proven to be an important option for the treatment of gouty arthritis. However, no IL-1β inhibitors are ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.